Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Iltamiocel by Cook MyoSite for Fecal Incontinence: Likelihood of Approval
Iltamiocel is under clinical development by Cook MyoSite and currently in Phase III for Fecal Incontinence. According to GlobalData, Phase...